The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in China, which is estimated to have the world’s highest number of people who are overweight or obese.
The popular weight-loss drug Wegovy has been available in Canada since early May, but anybody hoping to use it will have to shell out about $400 a month. One advocate says that lack of ...
The biopharmaceutical industry is set to see significant changes in the coming year, with anti-obesity drugs emerging as a major trend, according to industry experts. Obesity, a complex disease ...
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that regulates insulin levels and appetite. When celebrities started shedding ...
The team, led by Professor John Deanfield, conducted a five-year study to determine whether Wegovy, Ozempic and Rybelsus, could also reduce the risk of heart attacks, strokes or heart failure in ...
“Obesity is a condition that affects more than 40% of our adult population and when factoring in candidacy for injections, such as those with overweight and a weight-related condition, the ...
We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process. Ozempic is a glucagon-like peptide (GLP-1 ...
Public interest in weight loss drugs like Wegovy and Ozempic is surging, but national data on dispensing patterns in the United States is surprisingly scarce. Now, a national study from Michigan ...
SHANGHAI, June 6 (Reuters) - Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its ...
Have a question for Alyssa Northrop or our other editors? Ask here for a chance to be featured in a story. Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see ...
Appetite suppressing drugs are becoming a hot topic of conversation, with doctors now suggesting they could have important clinical benefits not just limited to weight loss. A new five-year study ...
Anti-obesity jabs could reduce the risk of heart attacks and strokes in people even if they fail to lose much weight, according to a study funded by a drug manufacturer. The five-year study ...